Date clarification: July 23, 2026 is today, not tomorrow. Dow is scheduled to report before the U.S. market opens on Thursday, July 23, 2026. This preview treats the release as still pending.
Dow enters earnings with unusually strong near-term pricing and margin momentum, driven primarily by severe Middle Eastern supply disruptions and its advantaged North American feedstock position. Management already raised its second-quarter operating EBITDA outlook from approximately $2.0 billion to $2.2 billion in June, so merely meeting consensus may not be enough to move the shares higher.
The decisive issue will be how much of the Q2 earnings surge can carry into Q3 and 2027. Investors must separate temporary geopolitical windfalls from durable improvements produced by cost reductions, European capacity closures and the Transform to Outperform program.
| Metric | Q2 expectation |
|---|---|
| Net sales | $11.95 billion |
| Operating EBITDA | $2.2 billion |
| Operating EPS | $1.26 |
Management’s latest EBITDA outlook of approximately $2.2 billion is about 10% above its original Q2 guidance. At consensus, the quarter would represent:
These are exceptional sequential improvements. Accordingly, the market’s real hurdle is likely above the published consensus.
Packaging & Specialty Plastics, Dow’s largest segment, should account for most of the sequential earnings improvement.
Dow entered the Middle Eastern disruption with an advantaged position:
Management said Dow captured a $0.10-per-pound polyethylene increase in March and a $0.30 increase in April. The company subsequently announced another $0.20 increase for June, which was not included in its updated $2.2 billion EBITDA forecast.
That creates potential upside, but investors should look beyond announced price increases and determine:
Management said in June that order books remained healthy and that it had not seen meaningful cancellations. Confirmation of that trend would support the argument that the current margin improvement can extend beyond Q2.
Dow indicated in June that Q2 and Q3 are normally similar earnings periods, although Q3 will include additional turnaround activity. Since then, conflict around the Strait of Hormuz has re-escalated, vessel traffic has fallen sharply and Brent crude recently moved above $94 per barrel.
This backdrop has two opposing effects on Dow.
A constructive report would pair a Q2 beat with guidance indicating that Q3 EBITDA can remain around Q2 levels—or at least materially above the pre-conflict earnings run rate. A strong quarter followed by a cautious Q3 outlook would likely be interpreted as peak earnings.
This is the main upside driver. Investors should expect substantial sequential improvement from polyethylene pricing, higher utilization and stronger integrated margins.
Key points to monitor:
Management previously suggested that Q2 segment earnings could approach or exceed mid-cycle levels. Commentary on whether margins are moving toward peak levels will be important.
This segment appears to be the biggest source of upside relative to Dow’s original Q2 forecast. Management cited improving polyols and MDI pricing when it raised companywide EBITDA guidance in June.
Investors should focus on:
The segment should benefit from seasonal coatings demand, downstream silicones growth and lower structural costs.
Relevant items include:
This segment is unlikely to determine the initial earnings beat or miss, but it is important to Dow’s argument that earnings are improving beyond polyethylene.
The geopolitical pricing benefit has not changed Dow’s longer-term need to lower its cost base. Management has outlined approximately $1.1 billion of 2026 EBITDA improvement from self-help actions, consisting of:
The original cost program was expected to be materially complete by the end of Q2, while Transform to Outperform benefits should become more heavily weighted toward the second half.
The strongest report would demonstrate both:
Investors should be wary if management attributes nearly all of the sequential earnings gain to external pricing without quantifying savings from actions under its control.
Dow finished Q1 with:
Q1 free cash flow was $621 million, but it benefited from the NOVA Chemicals litigation payment. Management has warned that rapidly rising prices may consume working capital in the near term, particularly through higher receivables, with stronger free-cash-flow generation expected in the second half.
Management has also said incremental cash from the earnings recovery will be directed toward deleveraging. Investors should therefore focus on:
At the current $0.35 quarterly dividend rate, the shares offer an annualized yield of approximately 4.5% based on the July 22 closing price. Given the prior dividend reduction, balance-sheet improvement is likely to take precedence over near-term dividend growth or aggressive repurchases.
Dow stopped recognizing additional Sadara equity losses in Q1 after recorded losses reached the level of its relevant obligations and commitments. Management previously described Sadara’s challenge as primarily a leverage and balance-sheet problem rather than an operating problem.
Former CEO Jim Fitterling had promised a midyear update on discussions with Saudi Aramco. Investors should listen for:
A resolution that limits future cash exposure would be positive even if it produces an accounting charge. A vague or delayed update would leave an important overhang unresolved.
Karen Carter became CEO on July 1, with Jim Fitterling moving to executive chair. Her first earnings call as chief executive will be closely watched for changes in capital allocation, European restructuring, cost discipline and portfolio strategy.
The transition appears designed to preserve continuity, but investors will want evidence that management remains willing to:
The tone of the call may matter nearly as much as the reported numbers.
Dow closed at $31.26 on July 22:
The stock has recently traded partly as a proxy for Middle Eastern supply conditions. This creates a challenging setup: renewed geopolitical disruption may help near-term earnings, but investors remain skeptical that current margins are sustainable.
The shares could therefore react more to changes in implied 2027 earnings power than to a conventional Q2 EPS beat.
This would suggest that consensus is underestimating both the duration of the supply disruption and Dow’s structural earnings improvement.
The stock reaction could be muted because the $2.2 billion EBITDA result has already been preannounced.
That outcome would reinforce the view that Q2 represents a geopolitical earnings spike rather than a sustainable recovery.
Dow should report a dramatic sequential earnings recovery, and the company has already established a relatively high bar with its $2.2 billion operating EBITDA update. The key is not whether Q2 is strong—it almost certainly will be—but whether management can demonstrate that the recovery extends into Q3 and is being reinforced by durable cost and portfolio improvements.
The most bullish combination would be pricing realization, stable demand, Q3 EBITDA resilience and accelerating free cash flow. Conversely, a headline beat accompanied by weaker guidance or poor cash conversion would indicate that investors are looking at peak rather than normalized earnings.